Amicus Therapeutics
Delaware corporation
Amicus Therapeutics, Inc. is an American biopharmaceutical company based in Princeton, New Jersey. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. As of April 2026, Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 60 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 55 % · cci-v1
5 active sensors·2 observations·0 historical changes·0 structured events·historical coverage 93 %·observed since 2026-09-13
Compare Amicus Therapeutics with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies